新疆医科大学学报

参考文献

[1] 《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.

[2] MARBER,MICHAEL.The future of myocardial injury biomarkers in cardiovascular disease:looking beyond cardiac troponins[J].Cardiovasc Res,2018,114(6):39-40.

[3] DAYAWANSA N ,GAO X ,WHITE D ,et al.Role of MIF in myocardial ischaemia and infarction:insight from recent clinical and experimental findings[J].Clin Sci,2014,127(3):149-161.

[4] YANG Y,CAI Y,WU G,et al.Plasma long non-coding RNA,CoroMarker,a novel biomarker for diagnosis of coronary artery disease[J].Clin Sci,2015,129(8):675-685.

[5] 吴庚泽,曾春雨.长链非编码RNA与心血管系统疾病的研究进展[J].中华心血管病杂志,2015,43(11):1010-1013.

[6] KLATTENHOFF C A,SCHEUERMANN J C,SURFACE LE,et al.Braveheart,a long noncoding RNA required forcardiovascular lineage commitment[J].Cell,2013,152(3):570-583.

[7] ZANGRANDO J,ZHANG L,VAUSORT M,et al.Identification of candidate long non-coding RNAs in response to myocardial infarction[J].Bmc Genomics,2014,15(1):460.

[8] BURD C,JECK W R,LIU Y,et al.Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk[J].PLoS Genet,2010,6(12):e1001233.

[9] KUMARSWAMY R,BAUTERS C,VOLKMANN I,et al.The circulating long non-coding RNA LIPCAR predicts survival in heart failure patients[J].Circ Res,2014,114(10):1569-1575.

[10] VAUSORT M,WAGNER DR,DEVAUX Y.Long noncoding RNAs in patients with acute myocardial infarction[J].Circ Res,2014,115(7):668-677.

[11] XIA Z.Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis[J].Acta Pharmacol Sin,2018,39(7):1155-1163.

[12] KIM K S,LEE H J,KIM K,ET A.Heart-type fatty acid binding protein as all adjunct to cardiac troponin-I for the diagnosis ofmyocardial infarction[J].J Korean Med Sci,2011,26(1):47-52.

[13] UITTERDIJK A,SNEEP S,VAN DUIN R W,et al.Serial measurement of hFABP and high-sensitivity troponin I post-PCI in STEMI:How fast and accurate can myocardial infarct size and no-reflow be predicted?[J].Am J Physiol Heart Circ Physiol,2013,305(7):1104-1110.

[14] VISWANATHAN K,KILCULLEN N,MORRELL C,et al.Heart-type fatty acid-binding protein predicts long-term mortality and reinfarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative[J].J Am Coil Cardiol,2010,55(23):2590-2598.

[15] BAKER J,TYTHER R,LIEBETRAU C,et al.Cardiac myosin-binding protein C:a potential early biomarker of myocardial injury[J].Basic Res Cardiol,2015,110(3):23.

[16] JACQUET S,YIN X,SICARD P,et al.Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis[J].Mol Cell Proteomics,2009,8(12):2687-2699.

[17] MARJOT J,KAIER T E,MARTIN E D,et al.Quantifying the release of biomarkers of myocardial necrosis from cardiac myocytes and intact myocardium[J].Clin Chem,2017,63(5):990-996.

[18] KAIER T E,ANAND A,SHAH A S,et al.Temporal relationship between cardiac myosin-binding protein C and cardiac troponin I in type 1 myocardial infarction[J].Clin Chem,2016,62(8):1153-1155.

[19] KAIER T E,TWERENBOLD R,PUELACHER C,et al.Direct comparison of cardiac myosin-binding protein C with cardiac troponins for the early diagnosis of acute myocardial infarction[J].Circulation,2017,136(25):1495-1508.

[20] KLINGENBERG R,AGHLMANDI S,LIEBETRAU C,et al.Cysteine-rich angiogenic inducer 61 (Cyr61):a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes[J].Eur Heart J,2017,38(47):3493-3502.

[21] HAO Y,YI S L,ZHONG J Q.Serum macrophage migration inhibitory factor levels are associated with angiographically complexcoronary lesions in patients with coronary artery disease[J].Genet Test Mol Biomarkers,2015,19(10):556-560.

[22] MüLLER I I,MüLLER K A,SCH?NLEBER H,et al.Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatoryresponse[J].PLoS One,2012,7(6):e38376.

[23] GAO X M,LIU Y,WHITE D,et al.Deletion of macrophage migration inhibitory factor protects the heart from severeischemia-reperfusion injury:a predominant role of anti-inflammation[J].J Mol Cell Cardiol,2011,50(6):991-999.

[24] FAN F,FANG L,MOORE X L,et al.Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia[J].J Am Heart Assoc,2016,5(7):e003128.

[25] WHITE D A,SU Y,KANELLAKIS P,et al.Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction[J].J Mol Cell Cardiol,2014,69:32-42.

[26] 余晗俏,俞章平,钟忆周,等.老年冠心病患者血清B型利钠肽和高敏C反应蛋白水平与临床预后的关系[J].中国心血管杂志,2017,22(2):113-116.